Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Hemasphere|July 20, 2023
Optical Genome Mapping Identifies Novel Recurrent Structural Alterations in Childhood <i>ETV6::RUNX1+</i> and High Hyperdiploid Acute Lymphoblastic LeukemiaDanielle Brandes, Layal Yasin, Karin Nebral, et al.
Blood|April 20, 2013
The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancyPolina Stepensky, Ann Saada, Marianne Cowan, et al.
Leukemia Research|July 20, 2015
Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patientsCai Chen, Christoph Bartenhagen, Michael Gombert, et al.
Cancer Research|February 28, 2016
Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung FibrosisFlorian Wirsdörfer, Simone de Leve, Federica Cappuccini, et al.
Blood|November 22, 2014
Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiencyPolina Stepensky, Anne Rensing-Ehl, Ruth Gather, et al.
Blood Advances|July 15, 2024
A brain organoid/ALL coculture model reveals the AP-1 pathway as critically associated with CNS involvement of BCP-ALLPhilip Gebing, Stefanos Loizou, Sebastian Hänsch, et al.
Cell Death & Disease|March 7, 2026
Epigenetic remodeling via HDAC6 inhibition amplifies anti-tumoral immune responses in myeloid leukemia cellsJulian Schliehe-Diecks, Jia-Wey Tu, Pawel Stachura, et al.
Cancer Research|November 23, 2021
BAFF Attenuates Immunosuppressive Monocytes in the Melanoma Tumor MicroenvironmentWei Liu, Paweł Stachura, Haifeng C Xu, et al.
Frontiers in Immunology|January 9, 2019
Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working GroupSimon Bomken, Jutte van der Werff Ten Bosch, Andishe Attarbaschi, et al.
Cell Death & Disease|December 6, 2023
Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cellsMelina Vogt, Niklas Dienstbier, Julian Schliehe-Diecks, et al.
Pageof 11